[1]Abdollahi A. LOT1 (ZAC/PLAGL1) and its family members mechanisms and function[J]. J Cell Physiol, 2007, 210(1): 16-25.
[2]War SA, Kumar U. Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis[J]. J Mol Signal, 2012, 7(1): 5-19.
[3] Zhang GZh, Ding Y, Liu J, et al. Correlation of ZAC with somatostatin and its receptor expression in gastric cancer tissues[J]. Acta Anatomica Sinaca, 2008, 39 (5): 703-707.(in Chinese)
张广政,丁一,刘键,等.胃癌组织中ZAC与生长抑素及生长抑素受体表达的相关性[J].解剖学报,2008,39(5):703-707.
[4]Weckbecker G, Lewis I, Albert R, et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects[J]. Nat Rev Drug Discov, 2003, 2(12): 999-1017.[5]May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein[J]. Oncogene, 1999,18 (2): 7621-7636.
[6]Shibui T, Higo Y, Tsutsui TW, et al. Changes in expression of imprinted genes following treatment of human cancer cell lines with nonmutagenic or mutagenic carcinogens[J]. Int J Oncol, 2008, 33(2): 351-360.
[7]Midorikawa Y, Yamamoto S, Ishikawa S, et al. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays[J]. Oncogene, 2006, 25(40): 5581-5590.
[8]Qi QG, Ma J, Da G, et al. Expression of zac in esophageal squamous cell carcinoma and its clinical significance[J]. Journal of the Fourth Military Medical University, 2007,28(19): 1793-1795.(in Chinese)
祁秋干,马军, 达嘎, 等.食管鳞癌中zac基因的表达及临床意义[J]. 第四军医大学学报, 2007,28(19):1793-1795.
[9]Jarmalaite S, Laurinaviciene A, Tverkuviene J, et al. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas[J]. Cancer Genet, 2011, 204(7): 398-404.
[10]Valleley EM, Cordery SF, Carr IM, et al. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation[J]. Genes Chromosomes Cancer, 2010, 49(5): 480-486.
[11]Theodoropoulou M, Tichomirowa MA, Sievers C, et al. Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly[J]. Int J Cancer, 2009, 125(9): 2122-2126.
[12]Theodoropoulou M, Zhang J, Laupheimer S, et al. Octreotide, a somatastatin analogue, mediate its antiproliferative action in pituitary tumor cells by altering phosphatidylinotol 3-kinase signaling and inducing Zac1 expression[J]. Cancer Res, 2006, 66(3): 1576-1582.
[13]Wang CH, Tang CW, Liu CL, et al. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway[J]. World J Gastroenterol, 2003, 9(9): 1904-1908.
[14]El-Salhy M. Effects of octreotide, galanin and serotonin on a human gastric cancer cell line[J]. Oncol Rep, 2005, 13(5): 787-791.
[15]Theodoropoulou M, Stalla GK, Spengler D. ZAC1 target genes and pituitary tumorigenesis[J]. Mol Cell Endocrinol, 2010, 326(1-2): 60-65.
|